News

The complaint – filed in the Supreme Court of the State of New York – alleges, among other things, that Protein Sciences (PSC) and its senior management engaged

The Phase Ib trial was a randomized, double-blind, placebo-controlled, multiple-ascending dose trial in 50 healthy adult male and female volunteers. Daily doses ranged from 15mg to 240mg and

Under the research agreement, Znomics will fund the program and will have the option to exclusively license the rights to the discoveries. With this collaboration, the company has

Par marketed meclizine prior to an explosion at the facility of its active pharmaceutical ingredients (API) supplier in February 2008. Par has since qualified a new API source

Patients in this open label study will be randomized into two treatment groups of 28 patients each. Each patient will receive six monthly infusions of either 500 or

Zynex’s operations continue to be conducted in its wholly owned subsidiary, Zynex Medical located in Littleton, Colorado. This new name is effective for stock trading purposes and now

The randomized, double-masked, placebo-controlled study will evaluate the safety and efficacy of Simulect as maintenance therapy in 56 patients. During the study, patients will undergo tapering of concomitant

The new in vitro transcription (IVT) reagent kits developed and manufactured by Asuragen will enable Affymetrix to deliver a complete solution to its molecular diagnostic partners. The products

Based on the outcome of the extensive European 318 study in adult patients with moderate-to-severe plaque psoriasis, the European Commission issued the marketing authorization for the EU for